Reply to: "Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account". [PDF]
Naddaf E.
europepmc +1 more source
NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis. [PDF]
Naddaf E +11 more
europepmc +1 more source
Loss of TDP-43 Splicing Repression Occurs in Myonuclei of Inclusion Body Myositis Patients. [PDF]
Ikenaga C +9 more
europepmc +1 more source
Whole-body-electro-myostimulation for the care of inclusion body myositis-A case report. [PDF]
Freitag N +6 more
europepmc +1 more source
Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account. [PDF]
Finsterer J, Zarrouk S.
europepmc +1 more source
Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis. [PDF]
Cantó-Santos J +19 more
europepmc +1 more source
Strapped for Strength: A Comparison Study of Dynamometry Techniques to Evaluate Knee Extensor Strength in Inclusion Body Myositis. [PDF]
Schütze K +7 more
europepmc +1 more source
Intramyocardial fatty infiltration lesion in sporadic inclusion body myositis: a case report. [PDF]
Redzepi B +8 more
europepmc +1 more source
Multi-omics analysis in inclusion body myositis identifies mir-16 responsible for HLA overexpression. [PDF]
Wijnbergen D +9 more
europepmc +1 more source

